Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors

Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors

US Patent 11191758 · Granted Dec 7, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating movement disorders with befiradol2025
Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudd2024
Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudd2024
Method for treating movement disorders with befiradol2021
Compounds for treating disorders sensitive to serotoninergic regulation controll2020
Compounds for treating disorders sensitive to serotoninergic regulation controll2020
Cycloalkylamines as monoamine reuptake inhibitors2020
Method for treating movement disorders with befiradol2020
Cycloalkylamines as monoamine reuptake inhibitors2018
Pyrroloquinoline derivatives as 5-HT6 antagonists, preparation method and use th2017
Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors2017
Cycloalkylamines as monoamine reuptake inhibitors2014